4//SEC Filing
Francomano Robert 4
Accession 0001104659-22-033927
CIK 0001390478other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 4:05 PM ET
Size
5.8 KB
Accession
0001104659-22-033927
Insider Transaction Report
Form 4
Francomano Robert
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-14+100,000→ 100,000 totalExercise: $5.23Exp: 2032-03-14→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]One-quarter (1/4) of the option shares will vest and became exercisable one year from the March 14, 2022 grant date, and the remainder will vest and become exercisable in equal monthly installments for thirty-six (36) months thereafter.
Documents
Issuer
SELLAS Life Sciences Group, Inc.
CIK 0001390478
Entity typeother
Related Parties
1- filerCIK 0001797467
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 4:05 PM ET
- Size
- 5.8 KB